Cost and impact of scaling up female genital mutilation prevention and care programs: Estimated resource requirements and impact on incidence and prevalence

PLoS One. 2021 Jan 28;16(1):e0244946. doi: 10.1371/journal.pone.0244946. eCollection 2021.

Abstract

Purpose: SDG 5.3 targets include eliminating harmful practices such as Female Genital Mutilation (FGM). Limited information is available about levels of investment needed and realistic estimates of potential incidence change. In this work, we estimate the cost and impact of FGM programs in 31 high burden countries.

Methods: This analysis combines program data, secondary data analysis, and population-level costing methods to estimate cost and impact of high and moderate scaleup of FGM programs between 2020 and 2030. Cost per person or community reached was multiplied by populations to estimate costs, and regression analysis was used to estimate new incidence rates, which were applied to populations to estimate cases averted.

Results: Reaching the high-coverage targets for 31 countries by 2030 would require an investment of US$ 3.3 billion. This scenario would avert more than 24 million cases of FGM, at an average cost of US$ 134 per case averted. A moderate-coverage scenario would cost US$ 1.6 billion and avert more than 12 million cases of FGM. However, average cost per case averted hides substantial variation based on country dynamics. The most cost-effective investment would be in countries with limited historic change in FGM incidence, with the average cost per case averted between US$ 3 and US$ 90. The next most effective would be those with high approval for FGM, but a preexisting trend downward, where cost per case averted is estimated at around US$ 240.

Interpretation: This analysis shows that although data on FGM is limited, we can draw useful findings from population-level surveys and program data to guide resource mobilization and program planning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Circumcision, Female / economics*
  • Circumcision, Female / statistics & numerical data
  • Community Health Services / economics
  • Female
  • Global Health / economics
  • Global Health / statistics & numerical data
  • Health Care Costs* / statistics & numerical data
  • Humans
  • Incidence
  • Prevalence
  • Resource Allocation / economics

Grants and funding

UNFPA (https://www.unfpa.org/) provided funding for this study to Avenir Health under Project ID ZZJ29TEC. Avenir Health employs Rachel Sanders, William Winfrey, and Nadia Carvalho. The UNFPA team members on the author list provided technical and administrative oversight on the project, and provided technical input on the study design, data collection and analysis, and the preparation of the manuscript.